These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35280421)

  • 1. Clinicopathologic and molecular characteristics of Chinese lung adenocarcinoma patients with
    Wang L; Liu Z; Wan Z; Jiang D; Zhang M; Liu S; Che N
    Ann Transl Med; 2022 Feb; 10(4):220. PubMed ID: 35280421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer.
    Gao X; Wei XW; Zheng MY; Chen ZH; Zhang XC; Zhong WZ; Yang JJ; Wu YL; Zhou Q
    J Thorac Dis; 2020 Oct; 12(10):5822-5832. PubMed ID: 33209414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characteristics of epidermal growth factor receptor exon 20 insertion mutations in non-small-cell lung cancer.
    Geng D; Guo Q; Huang S; Zhang H; Guo S; Li X
    Clin Transl Oncol; 2022 Feb; 24(2):379-387. PubMed ID: 34453698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of next generation sequencing and ARMS-PCR for detecting EGFR exon 20 insertion (ex20ins) mutations in Chinese non-small cell lung cancer patients.
    Xu Y; Jia L; Zhang L; Wang H; Jiang L; Feng X; Wei R; Yao Q; Ren M; Xue T; Li Y; Zhu X; Zhou X; Bai Q
    Transl Lung Cancer Res; 2024 May; 13(5):986-997. PubMed ID: 38854943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with
    Xu CW; Wang WX; Wang D; Wang QM; Pu XX; Zhu YC; Huang JH; Yu ZY; Cui ZL; Chen XH; Li JL; Fang Y; Wang H; Zhuang W; Lan SJ; Cai X; Zhang YB; Gao WB; Wang LP; She KL; Rao CZ; Zhou YF; Fang MY; Miao LY; Lei L; Lv TF; Song Y
    Transl Lung Cancer Res; 2020 Oct; 9(5):1853-1861. PubMed ID: 33209607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Afatinib in a Patient with NSCLC Harboring Novel
    Lin L; Wu X; Yan S; Zhu Y; Yan Z; Lv D; Ge H
    Onco Targets Ther; 2020; 13():9753-9757. PubMed ID: 33061454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR exon 20 insertion mutations in non-small cell lung cancer.
    Wang F; Li C; Wu Q; Lu H
    Transl Cancer Res; 2020 Apr; 9(4):2982-2991. PubMed ID: 35117654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinoma.
    Liu X; Jiang G; Sun X; Su G; Zhang X; Shen D; Yan N
    Front Oncol; 2023; 13():1275575. PubMed ID: 38023198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasets.
    Viteri S; Minchom A; Bazhenova L; Ou SI; Bauml JM; Shell SA; Schaffer M; Gu J; Rose JB; Curtin JC; Mahadevia P; Girard N
    Mol Oncol; 2023 Feb; 17(2):230-237. PubMed ID: 36269676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC.
    Ou SI; Hong JL; Christopoulos P; Lin HM; Vincent S; Churchill EN; Soeda J; Kazdal D; Stenzinger A; Thomas M
    J Thorac Oncol; 2023 Jun; 18(6):744-754. PubMed ID: 36738930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with
    Shi C; Xing R; Li M; Feng J; Sun R; Wei B; Guo Y; Ma J; Wang H
    Front Oncol; 2022; 12():949304. PubMed ID: 36119499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapy.
    Tian P; Zeng H; Ji L; Ding Z; Ren L; Gao W; Fan Z; Li L; Le X; Li P; Zhang M; Xia X; Zhang J; Li Y; Li W
    Lung Cancer; 2021 Oct; 160():50-58. PubMed ID: 34403912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data.
    Lu S; Guo A; Hu H; Ying X; Li Y; Huang Z; Xu W; Tao S; Hu X; Yan N; Zhang X; Shen D; Sasaki T; Arulananda S; Onodera K; He Z
    Transl Lung Cancer Res; 2024 Jun; 13(6):1296-1306. PubMed ID: 38973965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies for non-small cell lung cancer harboring EGFR exon 20 insertion mutations: narrative review.
    Watanabe N; Horio Y; Fujiwara Y
    Ann Transl Med; 2022 Dec; 10(23):1283. PubMed ID: 36618815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in Detection of EGFR Exon 20 Insertion Mutation and Targeted Therapies 
in Non-small Cell Lung Cancer].
    Wang Y; Chu T
    Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):135-147. PubMed ID: 36872052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Mechanism and Inhibitors Targeting EGFR Exon 20 Insertion (Ex20ins) Mutations.
    Chen H; Hu S; Patterson AV; Smaill JB; Ding K; Lu X
    J Med Chem; 2023 Sep; 66(17):11656-11671. PubMed ID: 37669428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)].
    Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
    Zhongguo Fei Ai Za Zhi; 2023 May; 26(5):325-337. PubMed ID: 37316442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and
    Luo Q; Chen L; Li Z; Cheng L; Zhang S; Zong Y; Li Q; Suda K; Santarpia M; Dalia S; Meng R
    Transl Lung Cancer Res; 2023 Nov; 12(11):2330-2341. PubMed ID: 38090524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.
    Zhang MS; Yeh YC; Huang HN; Lin LW; Huang YL; Wang LC; Yao LJ; Hung TC; Tseng YF; Lee YH; Liao WY; Shih JY; Hsieh MS
    PLoS One; 2024; 19(4):e0301120. PubMed ID: 38687753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of
    Cao Y; Lan D; Ke X; Zheng W; Zeng J; Niu N; Fu C; Deng W; Jin S
    Heliyon; 2024 Jun; 10(11):e32287. PubMed ID: 38912481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.